Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TC4R
|
|||
| Former ID |
DNCL001900
|
|||
| Drug Name |
Desmoteplase
|
|||
| Indication | Ischemic stroke [ICD-11: 8B11.5Z; ICD-9: 434.91] | Phase 3 | [1] | |
| Company |
Lundbeck Research
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00111852) Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2). U.S. National Institutes of Health. | |||
| REF 2 | Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke. 2003 Feb;34(2):537-43. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.